BRIEF published on 05/20/2024 at 20:35, 1 year 6 months ago Coastal Vision Medical Group Pioneers SMILE Pro With the VisuMax® 800 Coastal Vision SMILE Pro VisuMax 800 Vision Correction
PRESS RELEASE published on 05/20/2024 at 20:30, 1 year 6 months ago Coastal Vision Medical Group Pioneers SMILE Pro With the VisuMax(R) 800 Coastal Vision Medical Group is the first practice west of Dallas to offer ZEISS SMILE procedures using the VisuMax® 800 laser, enhancing patient comfort, safety, and recovery in vision correction surgeries Coastal Vision Medical Group VisuMax 800 Vision Correction ZEISS SMILE Laser Technology
PRESS RELEASE published on 02/15/2024 at 20:30, 1 year 9 months ago Grand Opening of Coastal Vision Medical Group's Advanced Office in Orange, CA Coastal Vision Medical Group celebrates the grand opening of its state-of-the-art eye care facility in Orange, CA, offering advanced services and technology for comprehensive eye care excellence Technology Coastal Vision Medical Group Eye Care Facility Orange, CA State-of-the-art Services
Published on 12/05/2025 at 02:35, 1 hour 58 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 33 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 28 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 33 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 3 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 42 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 8 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 18 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 23 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 33 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 48 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 49 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 32 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
